London · Delayed Price · Currency is GBP · Price in EUR BRAIN Biotech AG Statistics
Total Valuation
LON:0RFI has a market cap or net worth of GBP 41.31 million. The enterprise value is 32.18 million.
| Market Cap | 41.31M |
| Enterprise Value | 32.18M |
Important Dates
The last earnings date was Thursday, August 28, 2025.
| Earnings Date | Aug 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 21.85M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 9.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.90 |
| PB Ratio | 7.81 |
| P/TBV Ratio | 7.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.21 |
| EV / Sales | 0.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.06 |
Financial Position
The company has a current ratio of 2.39
| Current Ratio | 2.39 |
| Quick Ratio | 0.84 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.91 |
Financial Efficiency
Return on equity (ROE) is -98.79% and return on invested capital (ROIC) is -46.70%.
| Return on Equity (ROE) | -98.79% |
| Return on Assets (ROA) | -7.56% |
| Return on Invested Capital (ROIC) | -46.70% |
| Return on Capital Employed (ROCE) | -14.82% |
| Revenue Per Employee | 153,183 |
| Profits Per Employee | -33,416 |
| Employee Count | 318 |
| Asset Turnover | 0.73 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LON:0RFI has paid 37,717 in taxes.
| Income Tax | 37,717 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +47.44% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +47.44% |
| 50-Day Moving Average | 2.11 |
| 200-Day Moving Average | 2.61 |
| Relative Strength Index (RSI) | 56.84 |
| Average Volume (20 Days) | 67 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LON:0RFI had revenue of GBP 45.95 million and -10.02 million in losses. Loss per share was -0.46.
| Revenue | 45.95M |
| Gross Profit | 25.70M |
| Operating Income | -7.60M |
| Pretax Income | -10.01M |
| Net Income | -10.02M |
| EBITDA | -4.64M |
| EBIT | -7.60M |
| Loss Per Share | -0.46 |
Balance Sheet
The company has 9.03 million in cash and n/a in debt, giving a net cash position of 9.03 million.
| Cash & Cash Equivalents | 9.03M |
| Total Debt | n/a |
| Net Cash | 9.03M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 5.29M |
| Book Value Per Share | 0.24 |
| Working Capital | 15.05M |
Cash Flow
In the last 12 months, operating cash flow was -6.60 million and capital expenditures -1.33 million, giving a free cash flow of -7.93 million.
| Operating Cash Flow | -6.60M |
| Capital Expenditures | -1.33M |
| Free Cash Flow | -7.93M |
| FCF Per Share | n/a |
Margins
Gross margin is 55.93%, with operating and profit margins of -16.54% and -21.81%.
| Gross Margin | 55.93% |
| Operating Margin | -16.54% |
| Pretax Margin | -21.79% |
| Profit Margin | -21.81% |
| EBITDA Margin | -10.10% |
| EBIT Margin | -16.54% |
| FCF Margin | n/a |
Dividends & Yields
LON:0RFI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -24.27% |
| FCF Yield | -19.20% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |